Prelude Capital Management’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-1,000
Closed -$96K 1816
2013
Q3
$96K Buy
+1,000
New +$84.9K 0.02% 765

Other funds holding NUS

Prelude Capital Management's NUS Position: Q1 2026 in Review

Prelude Capital Management reduced its Nu Skin (NUS) stake by 30% in Q1 2026, selling an estimated $47.7K and leaving 12,313 shares worth $89.6K. The position accounts for 0.01% of the portfolio, ranked #1068.

Prelude Capital Management first reported a position in NUS in Q2 2013 and has held it in 27 quarters since. The position peaked at $326K in Q1 2024. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • Prelude Capital Management held 12,313 shares of Nu Skin worth $89.6K as of Q1 2026.
  • Prelude Capital Management sold 5,264 Nu Skin shares in Q1 2026, an estimated $47.7K.
  • Nu Skin made up 0.01% of Prelude Capital Management's portfolio in Q1 2026, its #1068 holding.
  • Prelude Capital Management first reported a position in Nu Skin in Q2 2013 and has held it in 27 quarters since.
  • Prelude Capital Management's Nu Skin position peaked at $326K in Q1 2024.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.